European Archives - Page 760 of 1217 - European Medical Journal

‘Memory’ Natural Killer Cells Involved in Hepatitis B Virus Immune Response

‘Memory’ Natural Killer Cells Involved in Hepatitis B Virus Immune Response

HEPATITIS B virus (HBV) vaccinations protect through immunological memory, i.e. the vaccine ‘trains’ the immune system…

Pulmonary Lipoma in an Atypical Location of the Pulmonary Fissure, Extirpated by Uniportal VATS – Case Report and Review of Literature

Lipomas are the most common benign tumour in adults and can manifest in all parts of the body. Although they are of high frequency, intrathoracic…

Are Undersized Airways the Cause of COPD in Nonsmokers?

Are Undersized Airways the Cause of COPD in Nonsmokers?

ONE IN FOUR patients with chronic obstructive pulmonary disease (COPD) have never smoked and the reasons behind this have long evaded researchers

Immunity to Respiratory Viruses by Targeting Killer T Cells

Immunity to Respiratory Viruses by Targeting Killer T Cells

COVID-19 has been shown to significantly affect the lungs. To understand how the immune cells of the lung respond to viral infection, researchers…

EMJ Nephrology 8 [Supplement 2] 2020

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a disease process characterised by necrosis and inflammatory damage to the…

Complement and Neutrophils in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis – Partners in Crime: Interviews with Two Key Opinion Leaders

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises a group of rare, necrotising inflammatory diseases.

Talking to Olli Rundgren

Olli Rundgren, CEO, Psyon Games, chats about the power of games and how they can positively impact health and behaviour. Olli discusses the formation of habits, the opportunity for education and data collection, and Psyon Games’ WHO endorsed game ‘Antidote’.

Convalescent Plasma Transfusion Therapy for COVID-19 Shows Promise

CONVALESCENT plasma transfusion for the treatment of severe COVID-19 is currently being trialled in the UK

Will Selective CAR T Cells for Acute Myeloid Leukaemia Replace Chemotherapy?

IMMUNOTHERAPY for acute myeloid leukaemia (AML) has shown promise in recent years, and now results from a study that demonstrated improved selectivity

Safety and Efficacy of Mavacamten in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: The MAVERICK-HCM Study

Hypertrophic cardiomyopathy (HCM) is a progressive primary myocardial disorder characterised by unexplained left ventricular…